MolOptimizer: A Molecular Optimization Toolkit for Fragment-Based Drug Design

被引：1

作者：

Soffer, Adam ^{[1
,2
]}

Viswas, Samuel Joshua ^{[1
,2
]}

Alon, Shahar ^{[3
]}

Rozenberg, Nofar ^{[3
]}

Peled, Amit ^{[3
]}

Piro, Daniel ^{[3
]}

Vilenchik, Dan ^{[4
]}

Akabayov, Barak ^{[1
,2
]}

机构：

[1] Ben Gurion Univ Negev, Chem Dept, IL-8410501 Beer Sheva, Israel

[2] Ben Gurion Univ Negev, Data Sci Res Ctr, IL-8410501 Beer Sheva, Israel

[3] Ben Gurion Univ Negev, Dept Software Engn, IL-8410501 Beer Sheva, Israel

[4] Ben Gurion Univ Negev, Sch Comp & Elect Engn, IL-8410501 Beer Sheva, Israel

来源：

MOLECULES | 2024年 / 29卷 / 01期

关键词：

cheminformatics; fragment screening; hit-to-lead optimization; DOCKING;

D O I：

10.3390/molecules29010276

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

MolOptimizer is a user-friendly computational toolkit designed to streamline the hit-to-lead optimization process in drug discovery. MolOptimizer extracts features and trains machine learning models using a user-provided, labeled, and small-molecule dataset to accurately predict the binding values of new small molecules that share similar scaffolds with the target in focus. Hosted on the Azure web-based server, MolOptimizer emerges as a vital resource, accelerating the discovery and development of novel drug candidates with improved binding properties.

引用

页数：8

共 50 条

[21] SERAPhiC: A Benchmark for in Silico Fragment-Based Drug Design
Favia, Angelo D.
Bottegoni, Giovanni
Nobeli, Irene
Bisignano, Paola
Cavalli, Andrea
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (11) : 2882 - 2896
[22] Fragment-based drug design: Combining philosophy with technology
Bartoli, Sandra
Fincham, Christopher I.
Fattori, Daniela
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (04) : 422 - 429
[23] GROUPBUILD - A FRAGMENT-BASED METHOD FOR DENOVO DRUG DESIGN
ROTSTEIN, SH
MURCKO, MA
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (12) : 1700 - 1710
[24] Fragment-based Drug Design Using NMR Methods
Puchades-Carrasco, Leonor
Pineda-Lucena, Antonio
EMAGRES, 2015, 4 (02): : 241 - 253
[25] CrystalDock: A Novel Approach to Fragment-Based Drug Design
Durrant, Jacob D.
Friedman, Aaron J.
McCammon, J. Andrew
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (10) : 2573 - 2580
[26] Concepts and Core Principles of Fragment-Based Drug Design
Kirsch, Philine
Hartman, Alwin M.
Hirsch, Anna K. H.
Empting, Martin
MOLECULES, 2019, 24 (23):
[27] Decomposition of Small Molecules for Fragment-Based Drug Design
Ivanov, Nikita N.
Shulga, Dmitry A.
Palyulin, Vladimir A.
BIOPHYSICA, 2023, 3 (02): : 362 - 372
[28] Fragment-Based Drug Design with CNS Therapeutic Targets
Surratt, Christopher K.
Pellegrene, Kendy A.
Wasko, Michael J.
Jean, Bernandie K.
Madura, Jeffry D.
FASEB JOURNAL, 2016, 30
[29] Computational Tools for In Silico Fragment-Based Drug Design
Mortier, Jeremie
Rakers, Christin
Frederick, Raphael
Wolber, Gerhard
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (17) : 1935 - 1943
[30] Linkers in fragment-based drug design: an overview of the literature
Grenier, Dylan
Audebert, Solene
Preto, Jordane
Guichou, Jean-Francois
Krimm, Isabelle
EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (09) : 987 - 1009

← 1 2 3 4 5 →